Misdiagnoses Among Challenges in Managing Cutaneous Lymphoma

Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.

Related Keywords

Canada ,Lakeridge ,New York ,United States ,Patrickm Brunner ,Raj Kumar Tuppal ,Lakeridge Health In Oshawa , ,Icahn School ,Mount Sinai Hospital ,Mount Sinai Winter Symposium ,Surgical Dermatology ,Lakeridge Health ,Non Hodgkins Lymphoma ,Cutaneous Lymphoma ,Lymphoma ,Malignant Lymphoma ,Skin Cancer ,Alignant Skin Neoplasm ,Transplantation Stem Cell ,Ransplantation Hematopoietic Stem Cell ,Hematopoietic Stem Cell Transplantation ,Stem Cell Transplantation ,Stem Cell Therapy ,Herapy Stem Cell ,Biomarker ,Iological Marker ,Dermatitis ,Biologic Therapy ,Transplantation Cellular ,Cellular Transplantation ,Oche ,